FibroGen Ownership | Who Owns FibroGen?

Overview Forecast RevenueFinancials Chart Transcripts

FibroGen Ownership Summary

FibroGen is owned by 45.70% institutional investors, 0.85% insiders, and 53.45% retail investors. Primecap management co/ca/ is the largest institutional shareholder, holding 13.80% of FGEN shares. Vanguard Capital Opportunity Inv is the top mutual fund, with 3.95% of its assets in FibroGen shares.

FGEN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	FibroGen	45.70%	0.85%	53.45%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Primecap management co/ca/	13.66M	13.80%	$12.19M
Vanguard group	5.89M	5.95%	$5.25M
Acadian asset management	3.36M	3.40%	$3.00M
Blackrock	2.41M	2.43%	$2.15M
683 capital management	2.15M	2.17%	$1.92M
Jacobs levy equity management	2.10M	2.13%	$1.88M
Millennium management	2.10M	2.13%	$1.88M
Gsa capital partners llp	1.33M	1.34%	$1.18M
Aqr capital management	1.32M	1.33%	$1.18M
Two sigma advisers, lp	1.19M	1.20%	$1.06M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
683 capital management	2.15M	0.14%	$1.92M
Vantage consulting group	195.71K	0.13%	$174.63K
Gsa capital partners llp	1.33M	0.08%	$1.18M
Xtx topco	475.72K	0.04%	$424.48K
Accel wealth management	95.60K	0.03%	$85.30K
Point72 asia (singapore) pte.	145.37K	0.03%	$129.71K
Armistice capital	1.00M	0.01%	$892.30K
Acadian asset management	3.36M	0.01%	$3.00M
Primecap management co/ca/	13.66M	0.01%	$12.19M
Jacobs levy equity management	2.10M	0.01%	$1.88M

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	2.10M	0.00%	1.99M
Gsa capital partners llp	1.33M	0.08%	1.33M
Goldman sachs group	1.09M	0.00%	990.34K
Acadian asset management	3.36M	0.01%	860.85K
Aqr capital management	1.32M	0.00%	769.59K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock	2.41M	-	-4.56M
State street	389.86K	-	-1.77M
Point72 asset management	-	-	-1.08M
Geode capital management	1.05M	0.00%	-1.02M
Pennant investors, lp	-	-	-768.40K

New Positions

Holder	Shares	% Assets	Change	Value
Gsa capital partners llp	1.33M	0.08%	1.33M	$1.18M
Point72 asia (singapore) pte.	145.37K	0.03%	145.37K	$129.71K
Nomura	139.60K	0.00%	139.60K	$124.56K
Franklin street advisors inc /nc	100.00K	0.01%	100.00K	$89.00K
Northeast financial consultants	54.70K	0.00%	54.70K	$48.81K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-35.00
Nisa investment advisors	-120.00
Larson financial group	-500.00
New york state common retirement fund	-779.00
Advisornet financial	-800.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	73	-33.64%	45,933,468	-18.80%	45	1.40%	22	-59.26%	29	-21.62%
Jun 30, 2024	110	-5.98%	56,568,035	-7.77%	57	1.44%	54	1.89%	37	-13.95%
Mar 31, 2024	117	11.43%	61,332,770	-12.47%	63	1.24%	53	23.26%	43	30.30%
Dec 31, 2023	105	-7.89%	70,070,472	2.53%	71	1.46%	43	-8.51%	33	-26.67%
Sep 30, 2023	114	-39.68%	68,339,922	-10.53%	69	1.07%	47	-50.53%	45	-6.25%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Capital Opportunity Inv	3.96M	3.95%	-1.26M
Vanguard Total Stock Mkt Idx Inv	2.92M	2.89%	-
PRIMECAP Odyssey Aggressive Growth	2.64M	2.63%	-1.27M
PRIMECAP Odyssey Growth	1.57M	1.56%	-826.01K
Vanguard Institutional Extnd Mkt Idx Tr	1.38M	1.37%	-
Vanguard Strategic Small-Cap Equity Inv	898.60K	0.90%	-
Fidelity Extended Market Index	586.66K	0.58%	59.66K
Vanguard US Opportunities Ins USD Acc	403.52K	0.40%	-6.00K
Vanguard Health Care ETF	320.98K	0.32%	-824.00
NT R2000 Value Index Fund - NL	308.69K	0.31%	34.29K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 12, 2024	Adib Deyaa	Chief Medical Officer	Buy	$25.88K
Mar 07, 2024	Wettig Thane	CEO	Buy	$95.47K
Sep 01, 2023	Henderson Jeffrey William	-	Sell	$2.06K
Aug 04, 2023	Henderson Jeffrey William	-	Sell	$3.82K
Jul 11, 2023	Henderson Jeffrey William	-	Sell	$5.38K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	1	-
2024 Q1	1	-
2023 Q4	-	-

FGEN Ownership FAQ

Who Owns FibroGen?

FibroGen shareholders are primarily institutional investors at 45.70%, followed by 0.85% insiders and 53.45% retail investors. The average institutional ownership in FibroGen's industry, Biotech Stocks , is 47.04%, which FibroGen falls below.

Who owns the most shares of FibroGen?

FibroGen’s largest shareholders are Primecap management co/ca/ (13.66M shares, 13.80%), Vanguard group (5.89M shares, 5.95%), and Acadian asset management (3.36M shares, 3.40%). Together, they hold 23.14% of FibroGen’s total shares outstanding.

Does Blackrock own FibroGen?

Yes, BlackRock owns 2.43% of FibroGen, totaling 2.41M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 2.15M$. In the last quarter, BlackRock decreased its holdings by -4.558M shares, a -65.42% change.

Who is FibroGen’s biggest shareholder by percentage of total assets invested?

683 capital management is FibroGen’s biggest shareholder by percentage of total assets invested, with 0.14% of its assets in 2.15M FibroGen shares, valued at 1.92M$.

Who is the top mutual fund holder of FibroGen shares?

Vanguard Capital Opportunity Inv is the top mutual fund holder of FibroGen shares, with 3.95% of its total shares outstanding invested in 3.96M FibroGen shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools